Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Healthtrust
Fish and Richardson
Cantor Fitzgerald
McKesson
Covington
Harvard Business School
Express Scripts
Citi

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090270

« Back to Dashboard

NDA 090270 describes MELPHALAN HYDROCHLORIDE, which is a drug marketed by Actavis Llc, Dr Reddys Labs Ltd, Fresenius Kabi Usa, Mylan Institutional, Par Sterile Products, Sagent Pharms, and West-ward Pharms Int, and is included in eight NDAs. It is available from seven suppliers. Additional details are available on the MELPHALAN HYDROCHLORIDE profile page.

The generic ingredient in MELPHALAN HYDROCHLORIDE is melphalan hydrochloride. There are twelve drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the melphalan hydrochloride profile page.
Summary for 090270
Tradename:MELPHALAN HYDROCHLORIDE
Applicant:Mylan Institutional
Ingredient:melphalan hydrochloride
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 090270
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MELPHALAN HYDROCHLORIDE melphalan hydrochloride INJECTABLE;INJECTION 090270 ANDA Mylan Institutional LLC 67457-195 N 67457-195-01
MELPHALAN HYDROCHLORIDE melphalan hydrochloride INJECTABLE;INJECTION 090270 ANDA Mylan Institutional LLC 67457-215 N 67457-215-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 50MG BASE/VIAL
Approval Date:Jun 9, 2009TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fish and Richardson
Deloitte
McKesson
Chubb
Farmers Insurance
UBS
Express Scripts
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.